The association between CHEK2 (Checkpoint Kinase 2) and Osteogenic Sarcoma is well established and manually curated, with its 4 contributing sources — 3 of them expert-curated — recording a known molecular basis and pathogenic and likely-pathogenic variants.
Sources4
Clinical variants137
Symptoms21
Compounds0
Trials0
Publications23
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.